News & Publications

Industry News

Jul
27

CMS ends hyperbarioc oxygen treatment experiment despite savings

The CMS will not continue an experiment that saved Medicare millions of dollars by reducing the use of non-emergency hyperbaric oxygen therapy. The treatment uses pressurized oxygen to help expedite wound healing, particularly for diabetic wound care. Since the CMS launched the experiment in 2015, its spending per beneficiary per quarter dropped by $60, according to a report released Monday by the CMS. Federal data shows the experiment saved the government $17.6 million by 2017.

Read More
Jul
13

Avoiding injuries

Pressure ulcers and the accompanying task of preserving residents’ skin integrity are never-ending challenges for long-term care providers. Not only is the treatment of pressure ulcers lengthy, it also costs an estimated $11 billion per year in the United States, with some $500 to $70,000 spent on each single wound.

Read More
Jul
13

RedDress Receives FDA 510(k) Clearance for RD1 System

RedDress Ltd announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its RD1 system. RD1 is an innovative wound care product which enables healthcare providers to produce in real time, in vitro whole blood clots, for use as a chronic wound care product. It has been developed to address the need for cost-effectiveness and clinical effectiveness of wound care.

Read More
Jul
13

Therapy can accelerate wound healing

Using microcurrent therapy along with traditional wound care approaches significantly reduces wound size and lessens pain, according to a study in the Journal of Wound Care. Harikrishna K.R. Nair, M.D., head of the wound care unit at Malaysia’s Hospital Kuala Lumpur, studied the effect of microcurrents on 100 chronic wound patients over four months in 2016. Their diagnoses included diabetic foot ulcers, venous leg ulcers and pressure ulcers.

Read More
Jul
13

Mölnlycke Acquires German Wound Care Company SastoMed GmbH

The world-leading medical solutions company, Mölnlycke, has acquired German wound care products company, SastoMed GmbH. The deal adds new, award-winning products to Mölnlycke’s offer – enabling it to further help healthcare professionals and patients by accelerating the wound healing process and treating chronic wounds. As of today, SastoMed GmbH joins the Mölnlycke family, bringing two innovative and complementary products to Mölnlycke’s wound care portfolio.

Read More